Catalent, Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • June 15th, 2020 • Catalent, Inc. • Pharmaceutical preparations • New York
Catalent, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this underwriting agreement (this “Agreement”), to issue and sell to RBC Capital Markets, LLC (the “Underwriter”), an aggregate of 8,912,500 shares of common stock, par value $0.01 per share (the “Stock”), of the Company. The aggregate of 7,750,000 shares of Stock to be sold by the Company are herein called the “Firm Shares” and the aggregate of up to 1,162,500 additional shares of Stock to be sold by the Company are herein called the “Optional Shares.” The Firm Shares and the Optional Shares that the Underwriter elects to purchase pursuant to Section 2 hereof are herein collectively called the “Shares.” The terms “supplement,” “amendment” and “amend” as used herein with respect to the Registration Statement, the Preliminary Prospectus, the Prospectus or the Pricing Prospectus (each as defined below) shall include all documents subsequently filed by the Company with the Secur
